Percutaneous transluminal dilatation of peripheral arteries: An analysis of factors predicting early success
|
|
- Kory Heath
- 6 years ago
- Views:
Transcription
1 SYMPOSIUM Interventional Radiology EDITOR'S NOTE: This symposium comprises the papers presented at the combined breakfast program of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery, North American Chapter, on June 18, 1983, at the scientific meeting in San Francisco. The subjects were selected by the Program Committee for their value in answering problems of practical clinical import. Percutaneous transluminal dilatation of peripheral arteries: An analysis of factors predicting early success Michael E. Lally, M.D., K. Wayne Johnston, M.D., and David Andrews, Ph.D., Toronto, Ontario, Canada Four hundred ninety-five patients undergoing peripheral arterial percutaneous transluminal dilatation (TLD) with the Gruntzig balloon catheter were studied prospectively to determine which factors could be used to predict a successful result from the procedure. Ten variables were recorded before the TLD. The procedure was considered a success at follow-up if both the clinical grade and the objective vascular laboratory results improved. The results of a logistic discriminant function analysis showed that three variables were associated with success of a TLD at 3 months: the site of the TLD, the severity of the lesion (i.e., stenosis or ocdusion), and the runoff. With these results, logistic regression analysis was used to estimate the chances of a successful result for all combinations of these significant variables. It is concluded that the early result ofa TLD is determined by the site of the TLD, the severity of the lesion, and the runoff. A table of the estimated chances of success for any combination of these variables has been constructed and accurately describes our patient population. (J VASC SURG 1984; 1: ) In spite of some skepticism, percutaneous transluminal dilatation (TLD) is becoming an increasingly popular method for managing selected patients with localized peripheral arterial occlusive disease. The low morbidity and complication rates associated with this procedure make it an attractive option in the treatment of selected patients with ischemic complaints, especially if the patient is a high operative risk or the symptoms are not disabling enough to warrant surgery. Despite these advantages, its overall success rate is lower than reconstructive surgery, and consequently it is desirable to determine which factors predict the result of the procedure. 1,2 The purposes of this article are to ascertain which variables are associated with the success of a From the Departments of Surgery and Biostatistics, The University of Toronto. Reprint requests: K. W. Johnston, M.D., Toronto General Hospital, 915 E-N Eaton Bldg., 200 Elizabeth St., Toronto, Ontario MSG 1L7, Canada. 704 TLD and to develop a mathematical model that will estimate the chances of success for all combinations of the significant variables. METHODS Patients. Data on 495 consecutive patients undergoing TLD at the Toronto General Hospital formed the basis for this study. The patients were included if they were referred for the procedure by one of the physicians or surgeons at the Toronto General Hospital or if their referring physiciarl agreed to allow us to assess and follow-up their patients objectively. Technique. The TLDs were performed by experienced vascular radiologists using the Gruntzig balloon catheter. The details of our technique are similar to Gruntzig's and have been described previ~ ously, a'4 For both iliac and femoral-popliteal dilatations, the catheter was usually introduced through the ipsilateral common femoral artery. Heparin, 5000 units, was given intra-arterially after the ca~ e-
2 Voiume 1 Number 5 September 1984 Percutaneous transluminal dilatation 705 ter was across the stenosis or occlusion and was not reversed at the end of the procedure. The patients received aspirin, 325 mg, and dipyridamole, 50 mg, orally three times daily starting 2 or 3 days prior to the procedure and continued for 1 month. No other long-term anticoagulation was used. Evaluation of results. The result of the TLD was determined with the use of a combination of subjective criteria and objective vascular laboratory measurements. 1"4 For a TLD to be called a success, the following criteria had to be satisfied: the patient's symptoms improving by at least one clinical grade; the ankle/brachial systolic pressure index increasing by at least 0.10; the Doppler pulsatility index increasing by more than 20%; monophasic Doppler waveforms becoming biphasic or triphasic; and the treadmill exercise distance doubling. Variables. Based on the resuks of previous vascular follow-up studies, we hypothesized that the following 10 variables might be related to the success of the procedure, and they were recorded prospectively: age, sex, presence and severity of diabetes, history of previous TLD at the same site, clinical indication for the procedure, site of the dilatation, ankle/brachial pressure ratio before the procedure, severity of the lesion (i.e., stenosis or occlusion), severity of arterial occlusive disease distal to the TLD (i.e., runoff), and occurrence of a complication. The subcategories of these variables are shown in Table I. Data analysis and statistical methods. The patient data were stored on a microcomputer and updated after each patient follow-up visit. The microcomputer was used to tabulate a frequency distribution of the characteristics of the patient population ~d to calculate the long-term results of TLDs by the life-table analysis method. In this study a larger computer was used for the logistic discriminant function analysis and the logistic regression analysis. A logistic discriminant function analysis was performed with the use of the SAS FUNCAT (SAS Institute, Inc., Cary, N.C.) subroutine to identify the variables associated with success. First, the program was used to determine which of the variables most significantly affected the result of the TLD. Second, to assure that none of the remaining variables had significance that might have been concealed in the initial discriminant analysis, the following procedure was adopted. The designated group of significant variables was combined with one of the remaining variables one by one and the FUNCAT procedure repeated. This procedure was repeated with each of the remaining variables, Table I. Variables and characteristics of the study population Variable Patients Subcategories and codes (%) Age (yr) < > Sex Male 65.1 Female 34.9 Diabetes Nil 80.1 Diet controlled 4.3 Oral hypoglycemics 8.3 Insulin dependent 7.3 Previous TLD No 92.9 Yes 7.1 TLD indication Claudication 82.2 Limb salvage 12.5 Other 4.3 Site Common iliac Common and external iliac 8.9 Femoral-popliteal 26.2 Other 8.4 Complications Nil 88.5 Death 0.6 Minor 10.3 Major 0.6 Ankle-pressure ratio < > Severity lesion Stenosis 79.6 Occlusion 20.4 Runoff No distal disease 46.0 <50% stenosis or 1-vessel 13.1 occlusion 50%-99% stenosis or vessel occlusion Complete occlusion or vessel occlusion and the significance of the added variable was assessed. Logistic rcgression analysis was used to estimate the chances of a successful result for all combinations of the significant variables. The success of the procedure dcpends on thc selected variables and logistic rcgression analysis gives estimates of this dependence in the form: L = K + KI~VARIABLE 1 + K2*VARIABLE 2 (1) +... Kn~VARIABLE n where K is a constant and K1, K2,... Kn are the coefficients associated with each ofthc variables and * represents multiplication. A variable may represent the presence of a particular condition. The probability of success of the TLD for each of the combinations of the variables is given by: Probability success = (c~+~l)/ (1 + e**l) (2) where e~+*l represents e raised to the Lth power.
3 706 Lally, Johnston, and Andrews Journal of VASCULAR SURGERY Table. Distribution of patients according to three significant variables < 50% Stenosis or 1 Vessel Occlusion 50-99% Stenosis or 2 Vessel Occlusion Occlusion or 3 Vessel Occlusion Common External Gommon Femorallilac Ilia and popliteal External Iliac -- S~enosis % successful TLDS D% Failed TLDS Height of each box is ~" # TED Patients Fig. 1. Results of logistic discriminant function analysis showing the three variables: site of the TLD, severity of lesion, and runoff. Heights of shaded areas are square root of number of failures; clear areas, square root of number of successes. (This format was used for purposes of scaling in figure.) Forty-one of the 495 procedures were excluded from the analysis because the site of the TLD was uncommon and there were insignificant numbers in the groups to be meaningful. In this study the factors determining early success (defined as success at 3 months) were analyzed. RESULTS Frequency distribution of variables. The characteristics of the study population are shown in Table I. Specifically, the frequency distribution of each of the variables and subcategories are listed. Logistic discriminant function analysis. The logistic discriminant function analysis identified the following three variables as being jointly significant and associated with early (3 months) success of a TLD: the site of the dilatation, the severity of the lesion (presence of stenosis or occlusion), and the status of the runoff. None of the other variables, when added to these three variables, were found to be significant. The distribution of the patients based on these variables is shown in Table. Fig. 1 summarizes the results of the discriminant analysis and demonstrates the interrelationship of the site of the TLD, the severity of the lesion, and the runoff. For each combination of these three significant variables, the height of each histogram is the square root of the number of cases. The shaded area represents the number of failed TLDs and the clear area the number of successes. This figure visually Site (No.) (No.) Common iliac I I I I I I laemoral-popliteal I I I = no runoff disease; = <50% distal stenosis or one- fibial artery occlusion; I = 50%-99% distal stenosis or two- tibial artery occlusion; = occlusion distal stenosis or three-tibial displays the data that have been used for the logistic regression analysis. Logistic regression analysis. With the use of logistic regression analysis, the values of the coefficients K, K1, K2... were determined for the significant variables. For each combination of site,' severity of lesion, and status of runoff; the percentage chance of success of a TLD was calculated by using equation 2. Table IA is a table of the estimated probabilities of success of a TLD for the different combinations of site, severity of lesion, and runoff. Table IB shows the 5% and 95% confidence limits for these estimates. In regard to site, for the different combinations of the variables, this table shows that the best chance for a successful TLD is at the external iliac site, although the common iliac and femoral-popliteal sites have results at 3 months that were nearly identical. When attempts are made to dilate multiple iliac lesions (i.e., a combined common and external iliac lesion), the chance of success is lower. For all combinations of variables, dilatation of a stenotic lesion consistently has a 20% to 25% greater chance of success than dilatation of an occluded artery, and the chances of success are progressively worse as the runoff became poorer. As illustrated in Table, the logistic regression
4 Volume 1 Number 5 September 1984 Percutaneous transluminal dilatation 707 Table IA. Chance of successful TLD at 3 months Site (%) (%) Common iliac I I I I I I Femoral-popliteal I I I = no runoff disease; = <50% distal stenosis or one-tibial artery occlusion; I= 50%-99% distal stenosis or two- tibial artery occlusion; = occlusion distal stenosis or three-tibial equation accurately predicted the probabilities of a successful dilatation. For each combination of variables, the number of TLDs predicted as being successful by the regression analysis closely agreed with the actual number of successful cases. DISCUSSION Transluminal dilatation is an alternative to vascular reconstructive surgery for the treatment of selected patients with peripheral arterial occlusive disease. Its advantages include low morbidity, low mortality, lower cost, short hospital stay, repeatability, low complication rate, and high patient acceptability. Also, TLD can be used as an adjunct to surgery to improve the inflow, thus limiting the extent of the operative procedure, and to treat postoperative complications of saphenous vein bypass grafts or progression of the occlusive disease. Since the mid-1970s, when TLD with the Gruntzig balloon catheter first became popular in North America, most investigators have reported only small retrospective series and have rarely used objective criteria for evaluating the results of the procedure. In contrast, our series is a prospective study of 495 TLDs, and the procedure was considered a success only if there was improvement of both the patients' symptoms and the objective measurements in the vascular laboratory. Table IB. 95% confidence limits of estimated chance of success at 3 months Site (%) (%) Common iliac I I I I I I Femoral-popliteal I I I = no runoff disease; = <50% distal stenosis or one-tibial artery occlusion; I= 50%-99% distal stenosis or two- tibial artery occlusion; = occlusion distal stenosis or three-tibial From a review of the literature it is difficult to determine which factors were important determinants of success; however, the following seem to be important. Site of the TLD. Most authors agree that the best results are obtained in the iliac segment, where success rates at 1 year are 76% to 93% and at 2 years 66% to 92%. 1'2"5-s The reported success rates for femoral-popliteal disease are 51% to 80% at i year and 46% to 75% at 2 years. 1-a'~'8-11 In the series reported here the cumulative success rates for all iliac TLDs at 1 year and 2 years was 71.1 _+ 2.9% (mean +_ 1 SE) and %, respectively, and for the femoral-politeal segment was 56.I +_ 4.8% and %. The results of dilatation of the profunda femoris artery, the common femoral and the tibial arteries have been less satisfactory. Severity of lesion. Some authors are reluctant to dilate occluded vessels because of the potential risk of arterial perforation; however, in our experience this concern is unfounded)7 In the femoralpoptiteal segment, Waltman et a12 reported a success rate of 87.5% for stenoses and 76% for occlusions. In our previous study we noted a 60% cumulative success rate at 1 year for stenoses and 40% for occlusions. Although the same trend has been re-
5 708 Lally, Johnston, and Andrews Journal of VASCULAR SURGERY Table. Number of TLDs predicted successful by logistic regression analysis/actual number of successful results Site (No.) (No.) Common lilac I 73/73 14/16 12/12 1/2 I 13/11 1/1 27/26 1/1 I 37/35 3/2 13/12 1/1 I 15/17 0/0 1V 27/28 1/1 I 14/17 3/4 2/2 1/0 I 2/0 0/0 8/8 1/0 FemoralTopliteal I 34/34 15/13 13/13 9/9 I 12/13 8/8 7/7 7/8 I = no runoff disease; = <50% distal stenosis or one- tibial artery occlusion; I = 50%-99% distal stenosis or two- tibial artery occlusion; = occlusion distal stenosis or three-tibial ported in the iliac segment, we have had excellent results with dilatation of occluded iliac arteries. 4'7 Runoff. There is general agreement that the results following vascular surgery are less satisfactory if the runoff is poor. The same has been reported with TLD, although some have suggested that the adequacy of the runoff is of little or no importance. 5"8"11'12 This divergence of opinion is likely due to the fact that the runoff has not been evaluated very critically. Other variables. Although we previously reported that the success rate was higher in patients with an ankle/brachial systolic blood pressure ratio higher than 0.35, 4 our present results and those of others have not observed a difference between the pre-tld pressure measurements in the successful and unsuccessful cases. 13 In general, it is to be expected that the results will be better when the indication for the procedure is claudicarion and lower when the patient has more severe disease and ischemic rest pain, ulceration, or gangrene are present. In the iliac segment Spence et al. 8 reported that the results were better if the indication was claudication compared with salvage, but in the femoral-popliteal segment the indication did not seem to be a factor. Freiman et al.12 noted an overall early success rate of 91.8% for claudication compared with 83% for sal- vage. In our previous analysis we found the presence of diabetes did not adversely affect the results. 1"4 In the iliac segment Spence et al. s reported that the results were the same in diabetics and nondiabetics, but in the femoral-popliteal area the 1-year success rate was 85.4% for nondiaberics and 53.5% for diabetics. Schmidtke et al.14 reported that age had little effect on the results, although we previously reported that patients younger than 55 years had a statistically better long-term result than the older patients. 1,4 The studies reported above have not clearly identified the factors associated with success of a TLD. Furthermore, they have not considered the important interrelationships between variables. When the effect of an individual variable on the outcome is assessed independently of the other variables, their interrelated effects are disregarded. In fact, it is to be expected that all of the significant variables will have interrelated effects, and consequently the effect of each individual variable on the result of the TLD will be confounded by the presence of other significant variables. This distortion in the estimate of the chances of a successful TLD can be handled by using logistic discriminant function analysis to identify the variables associated with success and logistic regression analysis to estimate the probabilities of success for a specific combination of significant variables. '~ In this study of the 10 variables analyzed the logistic discriminant function analysis identified only three as being associated with success at 3 months: the site of the TLD, the severity of the lesion, and the runoff. With the use of logistic regression analysis, a table of the estimated probabilities of success of a TLD at 3 months was constructed for the different combinations of site, severity of the lesion, and runoff. These analyses show that these three factors are strongly interrelated. The probability of early success of a TLD is high if the vessel is stenosed and the runoff is good. If the other factors are equal, common lilac, external iliac, and femoral-popliteal dilatations all have a high probability of early success, but the results are less sarisfactory when multiple iliac dilatations of both the common and the external iliac arteries are performed. The mathematical model appears to be quite accurate since the calculated number of successful dilatations closely agrees with the actual number of successes. Nonetheless the estimated probabilities of success in Table I were calculated based on the population of patients studied at the Toronto General Hospital. Therefore they apply only to this or a
6 Volume 1 Number 5 September 1984 Percutaneous transluminal dilatation 709 similar population. One should be cautious in applying this data to unknown or unrelated populations. The table of estimated probabilities have been developed to predict early success (3 months). In the future, with larger numbers of patients available for follow-up at 1 and 2 years, similar analyses will be performed to determine the variables that predict the long-term results. CONCLUSIONS By using discriminant function analysis we have dctcrmined which variables were associated with succcss of a TLD and have developed a table of predicted success rates for the different combinations of site, severity of the lesion, and runoff. No factor can be selected as being more important than the other two in predicting the result of the TLD. Rather, all three variables combined consistently have a significant effect on the result. We wish to acknowledge the financial support of Cook Inc., the assistance of Mrs. Maureen Rae who coordinated the follow-up study, and Mrs. Susan Ungaro and Mrs. Marilyn Bleach who performed the vascular laboratory studies. REFERENCES 1. Johnston KW, Colapinto RF. Peripheral arterial transluminal dilatation: Early results. Can J Surg I982; 25: Johnston KW. A surgeon's view of peripheral arterial transluminal dilatation. In: Bergan JJ, ed. Clinical surgery international, vol 7. New York: Churchill Livingstone, Gruntzig A, Kumpe DA. Technique of percutaneous transluminal angioplasty with the Gruntzig balloon catheter. AJR I979; i32: Johnston KW, Colapinto RF, Baird RJ. Transluminal dilatation--an alternative? Arch Surg 1982; 117: Neiman HL, Bergan JJ, Yao JS, Bran& TD, Greenberg M, O'Mara CS. Hemodynamic assessment of transluminal angioplasty for lower extremity ischemia. Radiology 1982; 143: Neiman IlL, Brandt TD, Greenberg M. Percutaneous transluminal angioplasty: an angiographer's viewpoint. Arch Surg 1981; 116: Roberts B, Ring EJ. Current stares of percutaneous transluminal angioplasty. Surg Clin North Am 1982; 62: Spence RK, Freiman DB, Gatenby R, Hobbs CL, Barker CF, et al. Long-term results of transluminal angioplasty of the iliac and femoral arteries. Arch Surg 1981; 116: Waltrnan AC, Greenfield AJ, Novelline RA, Abbott WM, et al. Transktminal angioplasty of the iliac and femoropopliteal arteries. Current status. Arch Surg 1982; 117: Gnmtzig A, Zeitler E. Coopcrative study of results of PTR in 12 different clinics. In: Zeitler E, Gruntzig A, Schoop W, eds. Percutaneous vascular recanalization. Berlin: Springer- Verlag, 1978: Lu CT, Zarins CK, Yang CF, Sottiurai V. Long-term arterial occlusion: Percutaneous transluminal angioplasty. AJR 1982; 138: Freiman DB, Spence R, Gatcnby R, Gertner M, Robcrts B, Berkowitz HD, et al. Transluminal angioplasty of the iliac and femoral arteries: Follow-up results without anticoagulation. Radiology 1981; 141: Kaufman SL, Barth KH, Kadir S, Williams GM, Smith GW, et al. Hemodynamic measurements in the evaluation and follow-up of transluminal angioplasty of the iliac and femoral arteries. Radiology 1982; 142: Schmidtke I, Zeitler E, Schoop W. Late results ofpercutaneous catheter treatment (Dotter's technique) in occlusion of the femoro-popliteal arteries, Stage. In: Zeitler E, Gruntzig A, Schoop W, eds. Percutaneous vascular recanalization. Berlin: Springer-Verlag, 1978: Anderson S, et al. Logit analysis. In: Anderson S, Auquier A, Hauck WW, Oakes D, Vandaele W, Weisberg HI, eds. Statistical methods for comparative studies. Techniques for bias reduction. New York: John Wiley & Sons, Inc, 1980:7-17,
Factors that determine the long-term results of percutaneous transluminal dilatation for peripheral arterial occlusive disease
Factors that determine the long-term results of percutaneous transluminal dilatation for peripheral arterial occlusive disease Jean F. Morin, M.D., F.R.C.S.(C), K. Wayne Johnston, M.D., F.R.C.S.(C), Larry
More informationReporting standards arterial endovascular. for lower extremity procedures
Reporting standards arterial endovascular for lower extremity procedures Samuel S. Ahn, MD, Robert B. Rutherford, MD, Gary J. Becker, MD, Anthony J. Comerota, MD, K. Wayne Johnston, MD, Gordon K. McClean,
More informationPractical Point in Holistic Diabetic Foot Care 3 March 2016
Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai
More informationTherapeutic Angiography
Therapeutic Angiography Edited by C. A. Athanasoulis H. L. Abrams E. Zeitler Contributors K. Amplatz. K.H. Barth J.J. Bookstein. D.e. Brewster V.P. Chuang A.M. Cohen R.F. Colapinto. A.B. Co simi. N.P.
More informationCardioVascular Radiology
Cardiovasc. Radiol. 2: 3-7, 1979 CardioVascular Radiology Percutaneous Transluminal Angioplasty (PTA) with the Griintzig Balloon Catheter: Technical Problems Encountered in the First Forty Patients B.T.
More informationStratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?
Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery
More informationJohn E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
More informationEndovascular Should Be Considered First Line Therapy
Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach
More informationImaging Strategy For Claudication
Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon
More informationCLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION
Donald L. Renfrew, MD Radiology Associates of the Fox Valley, 333 N. Commercial Street, Suite 100, Neenah, WI 54956 6/30/2012 Radiology Quiz of the Week # 79 Page 1 CLINICAL PRESENTATION AND RADIOLOGY
More informationPractical Point in Diabetic Foot Care 3-4 July 2017
Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University
More informationLower Extremity Peripheral Arterial Disease: Less is Sometimes More. Spence M Taylor, M.D.
Lower Extremity Peripheral Arterial Disease: Less is Sometimes More Spence M Taylor, M.D. President, Greenville Health System Clinical University Senior Associate Dean for Academic Affairs and Diversity
More informationThermal laser-assisted balloon angioplasty of the superficial femoral artery: A multicenter review of 602 cases
Thermal laser-assisted balloon angioplasty of the superficial femoral artery: A multicenter review of 602 cases David Rosenthal, MD, Felix A. Pesa, MD, Warren L. Gottsegen, MD, John R. Crew, MD, Charles
More informationArthroplasty after previous surgery: previous vascular problems
Arthroplasty after previous surgery: previous vascular problems Jacques Menetrey & Victoria B. Duthon Centre de médecine de l appareil locomoteur et du sport Swiss Olympic medical Center Unité d Orthopédie
More informationPATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE
PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential
More informationVasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy and Dental Medicine, Arad, Romania
ENDOVASCULAR TREATMENT FOR VASCULAR GRAFT RESTENOSIS Bogdan Totolici 1, Francisca Blanca Călinescu 1*, Ionel Droc 2, Carmen Neamţu 1 1 Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy
More informationNon-invasive examination
Non-invasive examination Segmental pressure and Ankle-Brachial Index (ABI) The segmental blood pressure (SBP) examination is a simple, noninvasive method for diagnosing and localizing arterial disease.
More informationPercutaneous Angioplasty for Infrainguinal Graft-related Stenoses
Eur J Vasc Endovasc Surg 14, 380-385 (1997) Percutaneous Angioplasty for Infrainguinal Graft-related Stenoses A. D. Houghton ~1, C. Todd 1, B. Pardy 2, P. R. Taylor ~ and J. F. Reidy ~ Departments of Surgery,
More informationSurgery is and Remains the Gold Standard for Limb-Threatening Ischemia
Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University Disclosure None What you
More informationDoes Deep Femoral Artery Revascularization as an Isolated Procedure Play a Role in Chronic Critical Limb Ischemia?
J ENDOVASC THER 119 CLINICAL INVESTIGATION Does Deep Femoral Artery Revascularization as an Isolated Procedure Play a Role in Chronic Critical Limb Ischemia? Nicolas Diehm, MD; Hannu Savolainen, MD*; Felix
More informationPeripheral Arterial Disease: A Practical Approach
Peripheral Arterial Disease: A Practical Approach Sanjoy Kundu BSc, MD, FRCPC, DABR, FASA, FCIRSE, FSIR The Scarborough Hospital Toronto Endovascular Centre The Vein Institute of Toronto Scarborough Vascular
More informationIntroduction History Preceded by Arterial Doppler and ABI Indications
Elise Brady, RVT, RDMS Introduction History Preceded by Arterial Doppler and ABI Indications 1) Abnormal ABI (within 2weeks of duplex) 2) Abnormal Doppler waveforms 3) Claudication 4) History of PVD 5)
More informationRadiologic Evaluation of Peripheral Arterial Disease
January 2003 Radiologic Evaluation of Peripheral Arterial Disease Grace Tye, Harvard Medical School Year III Patient D.M. CC: 44 y/o male with pain in his buttocks Occurs after walking 2 blocks. Pain is
More informationCurrent Status of Endovascular Therapies for Critical Limb Ischemia
Current Status of Endovascular Therapies for Critical Limb Ischemia Bulent Arslan, MD Associate Professor of Radiology Director, Vascular & Interventional Radiology Rush University Medical Center bulent_arslan@rush.edu
More informationN. J. Lalak, MB, BS, K. C. Hanel, MB, BS, FRACS, DDU, J. Hunt, RN, and A. Morgan, RN, RVT, DMU (vasc.), Kogarah, Australia
Duplex scan surveillance prosthetic bypass grafts of infrainguinal N. J. Lalak, MB, BS, K. C. Hanel, MB, BS, FRACS, DDU, J. Hunt, RN, and A. Morgan, RN, RVT, DMU (vasc.), Kogarah, Australia Purpose: Surveillance
More informationCase Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN
Critical Limb Ischemia: A Selective Approach to Revascularization Works Best None Disclosures Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center
More informationPedal Bypass With Deep Venous Arterialization:
Pedal Bypass With Deep Venous Arterialization: Long Term Result For Critical Limb Ischemia With Unreconstructable Distal Arteries Pramook Mutirangura Professor of Vascular Surgery Faculty of Medicine Siriraj
More informationMR Angiography in the evaluation of Lower Extremity Arterial Disease
March 2001 MR Angiography in the evaluation of Lower Extremity Arterial Disease Ted Mau, Harvard Medical School Year III Objectives We will cover: Indications for Magnetic Resonance Angiography (MRA) Basic
More information4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions
Central Venous Stenoses and Occlusions Management of Central Vein Stenoses Robert K. Kerlan Jr. M.D. Professor of Clinical Radiology and Surgery University of California San Francisco Key Questions What
More informationNoninvasive localization of arterial occlusive disease: A comparison of segmental Doppler pressures and arterial duplex mapping
Noninvasive localization of arterial occlusive disease: A comparison of segmental Doppler pressures and arterial duplex mapping Gregory L. Moneta, MD, Richard A. Yeager, MD, Raymond W. Lee, MD, and John
More informationSubintimal Angioplasty of Isolated Infragenicular Vessels in Lower Limb Ischemia: Long-term Results
411 CLINICAL INVESTIGATION Subintimal Angioplasty of Isolated Infragenicular Vessels in Lower Limb Ischemia: Long-term Results Hemant Ingle, MS, FRCS; Ahktar Nasim, MD, FRCS; Amman Bolia, FRCR; Guy Fishwick,
More informationV.A. is a 62-year-old male who presents in referral
, LLC an HMP Communications Holdings Company Clinical Case Update Latest Trends in Critical Limb Ischemia Imaging Amit Srivastava, MD, FACC, FABVM Interventional Cardiologist Bay Area Heart Center St.
More informationComparing patency rates between external iliac and common iliac artery stents
Comparing patency rates between external iliac and common iliac artery stents Eugene S. Lee, MD, Carol Coleman Steenson, MD, FACR, FSCVIR, Kristina E. Trimble, Michael P. Caldwell, BS, Michael A. Kuskowski,
More informationStudy population The study population comprised patients suffering from superficial femoral artery stenosis that required revascularisation.
Maintenance of patency following remote superficial femoral artery endarterectomy Galland R B, Whiteley M S, Gibson M, Simmons M J, Torrie E P, Magee T R Record Status This is a critical abstract of an
More informationRetrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty
Retrograde dorsalis pedis and posterior tibial artery access after failed antegrade angioplasty Poster No.: C-2067 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Scientific Exhibit Interventional
More informationCurrent Vascular and Endovascular Management in Diabetic Vasculopathy
Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery
More informationEndovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease
Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND
More informationDiagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC
Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,
More informationSAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS
SAFETY AND EFFECTIVENESS OF ENDOVASCULAR REVASCULARIZATION FOR PERIPHERAL ARTERIAL OCCLUSIONS LIBBY WATCH, MD MIAMI VASCULAR SPECIALISTS MIAMI CARDIAC & VASCULAR INSTITUTE FINANCIAL DISCLOSURES None 2
More informationOutcome and Good Indication of Laser Angioplasty
The 8th Congress of International YAG Laser Symposium Outcome and Good Indication of Laser Angioplasty Shoichi Takekawa, Hiraku Yodono, Tamaki Kimura, NaokoNishi, Hiroyuki Miura, Hiroshi Noda, Hideya Matsutani,
More informationClinical and morphological features of patients who underwent endovascular interventions for lower extremity arterial occlusive diseases
Original paper Clinical and morphological features of patients who underwent endovascular interventions for lower extremity arterial occlusive diseases Sakir Arslan, Isa Oner Yuksel, Erkan Koklu, Goksel
More informationLimb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017
Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene
More informationComplex Iliocaval Reconstruction PNEC. Seattle WA. Bill Marston MD Professor, Div of Vascular Surgery University of N.
Complex Iliocaval Reconstruction 2017 PNEC. Seattle WA Bill Marston MD Professor, Div of Vascular Surgery University of N. Carolina DISCLOSURES William Marston, MD Consultant/Advisory Board: Veniti, Cardinal
More informationChronic Critical Limb Ischemia: Diagnosis, Treatment and Prognosis
Chronic Critical Limb Ischemia: Diagnosis, Treatment and Prognosis JAMIE D. SANTILLI, M.D., and STEVEN M. SANTILLI, M.D., PH.D. University of Minnesota School of Medicine Minneapolis, Minnesota Chronic
More informationIntroduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
More informationRemote Endarterectomy Update
Remote Endarterectomy Update An endovascular alternative to bypass? BY JOHN D. MARTIN, MD Treating the superficial femoral artery (SFA) is still one of the most highly debated topics among vascular specialists.
More informationwith laser-assisted balloon and a rotary angioplasty Lessons learned
Experience angioplasty instrument: with laser-assisted balloon and a rotary angioplasty Lessons learned David L. Cull, MD, Richard L. Feinberg, MD, Jock R. Wheeler, MD, Stanley O. Snyder, Jr., MD, Roger
More informationProf. Nabil CHAKFE et coll.
Prof. Nabil CHAKFE et coll. For the Department of Vascular Surgery and Kidney Transplantation University Hospital of Strasbourg, FRANCE Popliteal artery entrapment: misdiagnosed Epidemiology Prevalence:
More informationResident Teaching Conference 3/12/2010
Resident Teaching Conference 3/12/2010 Goals Definition and Classification of Acute Limb Ischemia Clinical Assessment of the Vascular Patient History and Physical Diagnostic Modalities Management of Acute
More informationHypothesis: When compared to conventional balloon angioplasty, cryoplasty post-dilation decreases the risk of SFA nses in-stent restenosis
Cryoplasty or Conventional Balloon Post-dilation of Nitinol Stents For Revascularization of Peripheral Arterial Segments Background: Diabetes mellitus is associated with increased risk of in-stent restenosis
More information9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge
Disclosures State-of-the-Art Endovascular Lower Extremity Revascularization Promotional Speaker Jansen Pharmaceutical Promotional Speaker Amgen Pharmaceutical C. Michael Brown, MD, FACC al Cardiology Associate
More informationNCVH. What's New on the Vascular Horizons? Craig M. Walker, MD, FACC, FACP. New Cardiovascular Horizons
What's New on the Vascular Horizons? NCVH New Cardiovascular Horizons KNOW YOUR OPTIONS Craig M. Walker, MD, FACC, FACP Clinical Professor of Medicine Tulane University School of Medicine New Orleans,
More informationPeripheral Arterial Disease: the growing role of endovascular management
Peripheral Arterial Disease: the growing role of endovascular management Poster No.: C-1931 Congress: ECR 2012 Type: Educational Exhibit Authors: E. M. C. Guedes Pinto, E. Rosado, D. Penha, P. Cabral,
More informationSurgical transluminal femoropopliteal angioplasty: Multivariate analysis outcome
Surgical transluminal femoropopliteal angioplasty: Multivariate analysis outcome Jean-Pierre Becquemin, MD, A. Cavillon, MD, and F. Haiduc, MD, Creteil, France Purpose: The purpose of this study was to
More informationCan t See the Forest for the Trees: Transcollateral Crossing of Chronic Total Occlusions
Can t See the Forest for the Trees: Transcollateral Crossing of Chronic Total Occlusions Vinayak Subramanian, BS 1 ; George L. Adams, MD, MHS 2 From 1 Department of Biomedical Engineering, North Carolina
More informationNational Vascular Registry
National Vascular Registry Angioplasty Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or
More informationThe ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions
The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Dr. Sven Bräunlich Department of Angiology University-Hospital Leipzig, Germany Disclosure Speaker
More informationBrachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts
Brachytherapy for In-Stent Restenosis: Is the Concept Still Alive? Matthew T. Menard, M.D. Brigham and Women s Hospital Boston, Massachussetts Disclosure Speaker name: Matthew T. Menard... x I do not have
More informationDisclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are
An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical
More informationRecommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines
Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular
More informationEndovascular Repair of Combined Occluded Femoral and Popliteal Arteries
MEET 2013 Endovascular Repair of Combined Occluded Femoral and Popliteal Arteries ALI AMIN MD, FACS,FACC, RVT CHIEF OF ENDOVASCULAR INTERVENTIONS READING HOSPITAL AND MEDICAL CENTER READING, PA USA Chronic
More informationClinical and social consequences of Buerger disease
Clinical and social consequences of Buerger disease Takashi Ohta, MD, Hiroyuki Ishioashi, MD, Minoru Hosaka, MD, and Ikuo Sugimoto, MD, Aichi, Japan Purpose: This study was undertaken to assess the clinical
More informationPUT YOUR BEST FOOT FORWARD
PUT YOUR BEST FOOT FORWARD Bala Ramanan, MBBS 1 st year vascular surgery fellow Introduction The epidemic of diabetes and ageing of our population ensures critical limb ischemia will continue to grow.
More informationInterventional Treatment First for CLI
Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075 Disclosures Consultant
More informationShould We Be More Aggressive in the Treatment of Acute DVT?
DISCLOSURES Consultant Penumbra, Inc. UCSF Vascular Surgery Symposium April 6, 2017 K. Pallav Kolli, MD Assistant Professor of Clinical Radiology University of California, San Francisco 17 yo male, DVT
More informationCHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION
CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION ARMANDO MANSILHA MD, PhD, FEBVS UNIVERSITY HOSPITAL - PORTO Disclosure of Interest Speaker name: ARMANDO MANSILHA I have the following potential conflicts
More informationfibrinolysis in peripheral
Low-dose direct vascular disease fibrinolysis in peripheral Barry T. Katzen, M.D., Keith C. Edwards, M.D., Arthur S. Albert, M.D., and Arina van Breda, M.D., Alexandria, Va. One hundred thirty patients
More informationBEST-CLI Trial Study Concept and Current Status
BEST-CLI Trial Study Concept and Current Status Kenneth Rosenfield, MD, MHCDS National Co-PI BEST-CLI Trial Section Head, Vascular Medicine and Intervention Institute for Heart, Vascular, and Stroke Care
More informationInfluence of vein size (diameter) on infrapopliteal reversed vein graft patency
Influence of vein size (diameter) on infrapopliteal reversed vein graft patency Kurt R. Wengerter, MD, Frank J. Veith, MD, Sushil K. Gupta, MD, Enrico Ascer, MD, and Steven P. Rivers, MD, New York, N.Y.
More informationLaser Thermal Angioplasty for the Treatment of Obstruction of the Distal Superficial Femoral or Popliteal Arteries
1 i 69 Tirnothy C. McCowan1 Ernest J. Ferns1 Robert W. Barnes2 Max L. Baker1 Received November 1 0, 1987: accepted after revision January 21, 1988. T. C. McCowan is supported in part by The RadiOlOgical
More informationFOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in
11 Evaluation and Management of Peripheral Arterial Disease Joseph L. Mills, Sr., MD FOR THE 18 MILLION INDIVIDUALS with diabetes mellitus in the United States, foot problems ulceration, infection, and
More informationRadRx Your Prescription for Accurate Coding & Reimbursement Copyright All Rights Reserved.
Interventional Radiology Coding Case Studies Prepared by Stacie L. Buck, RHIA, CCS-P, RCC, CIRCC, AAPC Fellow President & Senior Consultant Week of November 19, 2018 Abdominal Aortogram, Bilateral Runoff
More informationValue of the duplex waveform at the common femoral artery for diagnosing obstructive aortoiliac disease
Value of the duplex waveform at the common femoral artery for diagnosing obstructive aortoiliac disease Sandra Spronk, MSc, a Pieter T. den Hoed, MD, PhD, b Leenoud C. W. de Jonge, MD, c Lukas C. van Dijk,
More informationClinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries
Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries Laura A. Karch, MD, Mark A. Mattos, MD, John P. Henretta, MD, Robert B. McLafferty, MD, Don
More informationIliac artery stenting in patients with poor distal runoff: Influence of concomitant infrainguinal arterial reconstruction
Iliac artery stenting in patients with poor distal runoff: Influence of concomitant infrainguinal arterial reconstruction Carlos H. Timaran, MD, a Takao Ohki, MD, a Nicholas J. Gargiulo, III, MD, a Frank
More informationPredictors for adverse outcome after iliac angioplasty and stenting for limb-threatening ischemia
Predictors for adverse outcome after iliac angioplasty and stenting for limb-threatening ischemia Carlos H. Timaran, MD, Scott L. Stevens, MD, Michael B. Freeman, MD, and Mitchell H. Goldman, MD, Knoxville,
More information2017 Cardiology Survival Guide
2017 Cardiology Survival Guide Chapter 2: Angioplasty/Atherectomy/Stent The term angioplasty literally means "blood vessel repair." During an angioplasty procedure, the physician inserts a catheter, with
More informationEasy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012
Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? Easy 89 yo Non-ambulatory Multiple failed interventions Forefoot and heel gangrene Andres Schanzer, MD
More informationDurability of vein graft revision: The outcome of secondary procedures
Durability of vein graft revision: The outcome of secondary procedures Dennis F. Bandyk, MD, Thomas M. Bergamini, MD, Jonathan B. Towne, MD, David D. Schmitt, MD, and Gary R. Seabrook, MD, Milwaukee, Wis.
More informationAngioplasty of the tibioperoneal vessels has had limited
Tibioperoneal (Outflow Lesion) Angioplasty Can Be Used as Primary Treatment in 235 Patients With Critical Limb Ischemia Five-Year Follow-Up Gerald Dorros, MD; Michael R. Jaff, DO; Ari M. Dorros, MD; Lynne
More informationSuperficial Femoral Artery Intervention: The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA
: The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA Peripheral arterial disease (PAD) of the superficial femoral artery (SFA) is the most common cause of intermittent claudication
More informationShould percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis?
Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis? Gerald S. Treiman, MD, Richard L. Treiman, MD, Laura Ichikawa,
More informationNational Vascular Registry
National Vascular Registry Bypass Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or postcode.
More informationDistal By-Pass procedures can reduce limb loss
Conventional treatment of the diabetic foot Distal By-Pass procedures can reduce limb loss Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department of Surgery,
More informationMandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium
Mandatory knowledge about natural history of coronary grafts P.Sergeant P. Maureira K.U.Leuven, Belgium Types of grafts Arterial ITA/IMA (internal thoracic/mammary artery) Radial artery Gastro-epiploïc
More informationAbdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease
Eur J Vasc Endovasc Surg (2010) 39, 714e718 Abdominal Aortic Doppler Waveform in Patients with Aorto-iliac Disease G. Styczynski a, *, C. Szmigielski a, J. Leszczynski b, A. Kuch-Wocial a, M. Szulc a a
More informationThere are multiple endovascular options for treatment
Peripheral Rotablator Atherectomy: The Below-the-Knee Approach to Address Calcium Head On Peripheral Rotablator s front-cutting, diamond-tipped burr provides stable rotation in calcified lesions. BY SONYA
More informationPerfusion Assessment in Chronic Wounds
Perfusion Assessment in Chronic Wounds American Society of Podiatric Surgeons Surgical Conference September 22, 2018 Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic Disclosures Speaker,
More informationIndications: following: embolization. artery that has diseases 5. The evaluation. of suspected. such entities. a cold hand. biopsy
Peripheral Arterial Ultrasound Protocol Using Color and Spectral Doppler Reviewed by: Mark Yuhasz, MD Last Review Date: January 2015 Contact: (866) 761 4200, Option 1 Indications: The indications for peripheral
More informationDisclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009
Disclosures Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach No disclosures No conflicts of interest Christopher D. Owens, MD Objectives Changing face of our patients presenting
More informationGLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE
GLOBAL VASCULAR GUIDELINES: A NEW PATHWAY FOR LIMB SALVAGE Michael S. Conte MD Professor and Chief, Vascular and Endovascular Surgery Co-Director, Center for Limb Preservation Co-Director, Heart and Vascular
More informationperipheral arterial disease; PAD endovascular therapy; EVT
15 603 610 2006 1 1 1 1 1 2 3 1 2 peripheral arterial disease; PAD endovascular therapy; EVT chronic total occlusion; CTO CTO TASC-C DEVT 1997 7 2006 4 PAD 171 218 EVTCTO60 61 51 9 70 8.6cm 8049 1 9 2
More informationComparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)
Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE) Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
More informationRobert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015
Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015 Disclosure I have nothing to disclose Randomized Controlled Studies In SFA Technology: What s The Best Tool For
More informationPAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014
PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare
More informationLower Extremity Arterial Duplex Evaluation
VASCULAR TECHNOLOGY PROFESSIONAL PERFORMANCE GUIDELINES Lower Extremity Arterial Duplex Evaluation This Guideline was prepared by the Professional Guidelines Subcommittee of the Society for Vascular Ultrasound
More informationAngiographic follow-up after laser-assisted balloon angioplasty
Angiographic follow-up after laser-assisted balloon angioplasty Bhagwan Satiani, MD, B. Mohan Das, MD, Patrick S. Vaccaro, MD, and Diane Gawron, RN, Columbus, Ohio Purpose: The purpose of this study was
More information